Clinical Trials Browser

Burkitt Lymphoma, Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Experimental, Recurrence, Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

NCT01279707 2014-07-14

MARALL

Phase 1/2 Unknown

55 enrolled

Lymphoid

Burkitt Lymphoma, Recurrence

NCT02004795 2013-12-09

BNCT and IG-IMRT for Recurrent Head and Neck Cancer

Phase 1/2 Unknown

28 enrolled

Head & Neck

Head and Neck Neoplasms, Recurrence

NCT01686386 2013-04-05

Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

Phase 1/2 Unknown

60 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT01010243 2012-05-30

MM03

Phase 1/2 Unknown

54 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT01385072 2011-11-16

Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies

Phase 1/2 Unknown

10 enrolled

Recurrence

NCT00635557 2011-03-25

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Phase 1/2 Unknown

30 enrolled

CNS

Glioblastoma, Recurrence

NCT01322776 2011-03-25

Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma

Phase 1/2 Unknown

40 enrolled

Lymphoid

Recurrence, Lymphoma, Mantle-Cell

Clinical Trials

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

BORTEM-17

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma

Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

CT32

Lorlatinib Combinations in Lung Cancer

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

CAR-T

CAR-T

Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma

Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

TRANSATRA

CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）

CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）

NKEXPGD2

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

IDPR-HSCT

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma

TMI-ASCT

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Treatment of Acute Leukemia Relapse After Allotransplantation

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

MARALL

BNCT and IG-IMRT for Recurrent Head and Neck Cancer

Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

MM03

Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma